Popular Articles

Spectranetics Receives CE Mark Approval For ThromCat(R)XT
Spectranetics Corporation (Nasdaq:SPNC) reported that it has received the CE mark approval for its next-generation ThromCat® XT Thrombus Removal System, a single-use, disposable device indicated for mechanical removal of thrombus from native coronary arteries and infra-inguinal arteries. The launch of the product will commence immediately within the European Union. The approval triggers a milestone payment of $1.5 million pursuant to the Company"s Amended Development and Regulatory Services agreement with Kensey Nash Corporation (Nasdaq:KNSY).

Efforts To 'Fix' Medicare Payments At Center Of Reform
The Wall Street Journal reports: "A plan to end a program that would cut government payments to doctors is emerging as the flash point in the debate over whether President Barack Obama"s effort to overhaul the health system would increase the federal budget deficit. The proposal was crucial to winning support from the politically powerful American Medical Association -- but it has also made it tougher to argue that the health overhaul would pay for itself. ... Health and Human Services Secretary Kathleen Sebelius, appearing on NBC"s "Meet the Press," said costs associated with the legislation could be reduced significantly if lawmakers included the administration"s recommendation to bolster the power of the Medicare Payment Advisory Commission, or MedPAC, to set Medicare payment policies.
News of the day
New Cases Of Alzheimer's And Dementia Continue To Rise, Even In The 'Oldest Old'
The number of people with Alzheimer"s and dementia - both new cases and
Sexual Health

Deadly Skin Cancer Cases Hit Record High

The number of people diagnosed with the deadliest form of skin cancer has crashed through the 10,000 barrier after an alarming rise in new cases, according to the latest Cancer Research UK figures revealed today. As bank holiday temperatures are predicted to be the highest of the year so far experts are concerned about the dramatic rise in the number of people diagnosed with malignant melanoma each year. They believe the reasons include binge tanning - either at home or abroad on foreign holidays - and reflects behaviour since package holidays became popular. Cases of malignant melanoma - the potentially fatal form of skin cancer - have risen by more than 650 since last year, taking the number of cases diagnosed in the UK to over 10,400. And, Cancer Research UK statisticians predict that by the year 2024 this figure could soar to more than 15,500 - making malignant melanoma the fourth most common cancer for men and for women of all ages. During the last 30 years malignant melanoma rates have more than quadrupled - rising from 3.4 people per 100,000 in 1977 to 14.7 per 100,000 in 2006. The number of women being diagnosed with malignant melanoma in the UK outweighs men by over 700; 5600 women are diagnosed each year compared to 4800 men. But, more men die from malignant melanoma than women. And the rates of melanoma in men have increased more than fivefold whereas in women they have more than tripled. Sara Hiom, Cancer Research UK"s director of health information; said: "These figures show that a worrying number of people are being diagnosed with this potentially fatal disease. "With the rates of malignant melanoma in the UK rising faster than any other cancer it"s more important than ever that people are aware of the dangers of getting burnt, either in the sun or from using sunbeds. "Most melanoma skin cancers are caused by over exposure to UV rays given off by the sun and sunbeds. But, crucially, if people are careful not to redden or burn, especially if they have fair, freckly or moley skin then most cases of malignant melanoma could be prevented. "We advise people to enjoy the sun safely by spending time in the shade in the middle of the day, covering up with appropriate cool clothing and sunglasses and applying plenty of sun cream of at least factor 15." Notes *Latest available figures from 2006 ** Northern Ireland is excluded from these figures as rates were not calculated until 1993 Cancer Research UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):